510(k) device
CIRRUS HD-OCT Model 6000
Carl Zeiss Meditec, Inc. · Tomography, Optical Coherence (OBO, Class II) · First FDA decision May 5, 2009, newest May 17, 2024GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
510(k) pathway
Device trials
10
Naming "CIRRUS HD-OCT"
MAUDE reports
2
Brand "CIRRUS HD-OCT", since 2015
PubMed studies
533
Mentioning "CIRRUS HD-OCT"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CIRRUS HD-OCT Model 6000
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
K233933 · Decided May 17, 2024 · 155 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- CIRRUS HD-OCT510(k)
K222200 · Decided Apr 13, 2023 · 262 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- CIRRUS HD-OCT510(k)
K181534 · Decided Feb 15, 2019 · 249 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CIRRUS HD-OCT", any status and sponsor, newest update first.
- (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000Pivotal-lookingRecruiting
Carl Zeiss Meditec-Dublin CoCeNot on our public-company list
NCT07680244 · 400 participants (planned) · Start May 23, 2025 · Primary completion Aug 2026
Device: PathFinder 1.0 on CIRRUS HD-OCT · For: Epiretinal Membrane; Dry Age Related Macular Degeneration; Macular Abnormalities and 7 more
Sites: Tucson, Arizona; Mountain View, California; San Francisco, California · 6 sites in all
Okan UniversityAcademic, hospital or other
NCT06674369 · 15 participants · Start Aug 28, 2022 · Primary completion Oct 18, 2022
Device: Peli prism for hemianopia · For: Homonymous Hemianopsia
Sites: Istanbul, Turkey (Türkiye)
Topcon CorporationNot on our public-company list
NCT04701931 · 135 participants · Start Jan 7, 2021 · Primary completion Nov 9, 2022
Device: Maestro2 OCTA; Cirrus HD-OCT 5000 and 1 more · For: Retina Condition Followed by Fluorescein Angiography Imaging
Sites: Santa Ana, California; Augusta, Georgia
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CIRRUS HD-OCT", and for the whole product code for context.
This brand
2 reports: 2 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
- ZEISS CIRRUS HD-OCT 4000 RETINA TOMOGRAPHERMalfunction
MW5159680 · Received Sep 17, 2024 · Event dated Sep 11, 2024
Device type: Tomography, Optical Coherence (OBO)
Patient problem as coded: Insufficient Information
- CIRRUS HD-OCT 6000Malfunction
2918630-2023-00001 · Received Apr 4, 2023 · Event dated Mar 16, 2023
Device type: Tomography, Optical Coherence (OBO)
Device problem as coded: Unintended Electrical Shock
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- CIRRUS HD-OCT, Models 5000 AngioPlex and 6000 AngioPlexOpen, Classified
Z-0723-2022 · Started Jan 14, 2022
Reason given: Optic nerve head angiography scan to be turned off due to its distribution without pre-market clearance.
Cause as FDA categorized it: No Marketing Application · Device type: Tomography, Optical Coherence (OBO)
- Chassis Label - "CIRRUS HD-OCT Rx-Only" Product Label Exterior RX - "CIRRUS HD-OCT Model 6000"Open, Classified
Z-2227-2021 · Started Jul 8, 2021
Reason given: Due to failure to acquire pre-market clearance for its high resolution tomographic/biomicroscope imaging device (Model 6000) prior to commercializing the device.
Cause as FDA categorized it: No Marketing Application · Device type: Tomography, Optical Coherence (OBO)
Z-2126-2011 · Started Mar 10, 2011 · Posted by FDA May 2, 2011
Reason given: A software defect exists in versions 5.0.0 and 5.1.0 where when following a specific workflow, exam data may be saved under the name of the first patient
Cause as FDA categorized it: Software design · Device type: Tomography, Optical Coherence (OBO)
1 more recall records with a free account
Published research
The most relevant PubMed records for "CIRRUS HD-OCT"[tiab]. The summary above synthesizes these.
- Factors Affecting Cirrus-HD OCT Optic Disc Scan Quality: A Review with Case Examples.
Hardin JS, Taibbi G, Nelson SC, et al. · J Ophthalmol · 2015Review
- Accuracy of Cirrus HD-OCT and Topcon SP-3000P for measuring central corneal thickness.
Calvo-Sanz JA, Ruiz-Alcocer J, Sánchez-Tena MA · J Optom · 2018
- Photobleaching by Spectralis Fixation Target.
Tomasso L, Benatti L, Carnevali A, et al. · JAMA Ophthalmol · 2016
- Multimodal ocular evaluation in hemodialysis patients.
Mayali H, Altinisik M, Sarigul C, et al. · Int Ophthalmol · 2021
- Comparison of macular thickness between Cirrus HD-OCT and Stratus OCT.
Kakinoki M, Sawada O, Sawada T, et al. · Ophthalmic Surg Lasers Imaging · 2009Comparative Study, Research Support, Non-U.S. Gov't
- Cirrus HD-OCT short-term repeatability of clinical retinal nerve fiber layer measurements.
Wong E, Yoshioka N, Kalloniatis M, et al. · Optom Vis Sci · 2015Observational Study, Research Support, Non-U.S. Gov't
- Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes.
Manjunath V, Fujimoto JG, Duker JS · Retina · 2010Comment, Letter
- Influence of OSCAR-IB Criteria on Test-Retest Reliability of Cirrus HD-OCT Retinal Thickness Measurements in People With Multiple Sclerosis.
Bacchetti A, Lin TY, McCormack B, et al. · Neurol Neuroimmunol Neuroinflamm · 2025
- Central corneal thickness measurement with Cirrus HD-OCT and Topcon SP-3000P.
De Bernardo M, Salzano FA, Rosa N · J Optom · 2018Comment
- Ability of cirrus HD-OCT optic nerve head parameters to discriminate normal from glaucomatous eyes.
Mwanza JC, Oakley JD, Budenz DL, et al. · Ophthalmology · 2011Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Haab striae: Optical coherence tomographic analysis.
Benito-Pascual B, Pascual-Prieto J, Martínez-de-la-Casa JM, et al. · J Fr Ophtalmol · 2019Case Reports
- An Ensemble Learning Artificial Intelligence Model for Alzheimer's Disease Detection Using OCT.
Ran AR, Hu X, Hui HYH, et al. · Ophthalmol Sci · 2026
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
- iVueOptovue, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.